Medical Complications After Subarachnoid Hemorrhage

Neurosurgery Clinics of North America

Volumn 21, Issue 2, 2010, Pages 325-338

  Wartenberg, Katja E ^a   Mayer, Stephan A ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Department of Orthopaedic Surgery   (United States)

Author keywords

Anemia; Blood transfusion; Fever; Hyperglycemia; Medical complications; Subarachnoid hemorrhage

Indexed keywords

ANTIHYPERTENSIVE AGENT; BUSPIRONE; CLONIDINE; DEXMEDETOMIDINE; FENTANYL; GLUCOSE; HYPERTENSIVE FACTOR; INSULIN; MAGNESIUM SULFATE; PARACETAMOL; PETHIDINE; POTASSIUM; PROPOFOL; ROCURONIUM; VECURONIUM;

ANEMIA; BLOOD PRESSURE; BLOOD TRANSFUSION; BRAIN INJURY; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; DRUG MECHANISM; ECHOCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; FEVER; GASTROINTESTINAL HEMORRHAGE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPONATREMIA; HYPOTENSION; HYPOXIA; INDUCED HYPOTHERMIA; INFECTION; KIDNEY FAILURE; LABORATORY TEST; LIVER FAILURE; LUNG DISEASE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SHIVERING; STUNNED HEART MUSCLE; SUBARACHNOID HEMORRHAGE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANEMIA; FEVER; HEART DISEASES; HUMANS; HYPERGLYCEMIA; INFECTION; LUNG DISEASES; SUBARACHNOID HEMORRHAGE; WATER-ELECTROLYTE BALANCE;

EID: 77951042482     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2009.10.012     Document Type: Review

References (129)

1. Claassen J., Vu A., Kreiter K.T., et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 2004, 32:832.
2. Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 2003, 34:1852.
3. Qureshi A.I., Suarez J.I., Bhardwaj A., et al. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2000, 28:824.
4. Claassen J., Carhuapoma J.R., Kreiter K.T., et al. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002, 33:1225.
5. Kassell N.F., Torner J.C., Haley E.C., et al. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg 1990, 73:18.
6. Niskanen M.M., Hernesniemi J.A., Vapalahti M.P., et al. One-year outcome in early aneurysm surgery: prediction of outcome. Acta Neurochir (Wien) 1993, 123:25.
7. Rabinstein A.A., Friedman J.A., Nichols D.A., et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. AJNR Am J Neuroradiol 2004, 25:1778.
8. Rosengart A.J., Schultheiss K.E., Tolentino J., et al. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:2315.
9. Sarrafzadeh A., Haux D., Kuchler I., et al. Poor-grade aneurysmal subarachnoid hemorrhage: relationship of cerebral metabolism to outcome. J Neurosurg 2004, 100:400.
10. Torner J.C., Kassell N.F., Wallace R.B., et al. Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study. Neurosurgery 1981, 9:506.
11. Naidech A.M., Janjua N., Kreiter K.T., et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 2005, 62:410.
12. Baldwin M.E., Macdonald R.L., Huo D., et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004, 35:2506.
13. Claassen J., Bernardini G.L., Kreiter K., et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 2001, 32:2012.
14. Wartenberg K.E., Schmidt J.M., Claassen J., et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006, 34:617.
15. Naidech A.M., Bendok B.R., Tamul P., et al. Medical complications drive length of stay after brain hemorrhage: a cohort study. Neurocrit Care 2009, 10:11.
16. Solenski N.J., Haley E.C., Kassell N.F., et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995, 23:1007.
17. Dorhout Mees S.M., Luitse M.J., van den Bergh W.M., et al. Fever after aneurysmal subarachnoid hemorrhage: relation with extent of hydrocephalus and amount of extravasated blood. Stroke 2008, 39:2141.
18. Fernandez A., Schmidt J.M., Claassen J., et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology 2007, 68:1013.
19. Naidech A.M., Bendok B.R., Bernstein R.A., et al. Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery 2008, 63:212.
20. Oliveira-Filho J., Ezzeddine M.A., Segal A.Z., et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001, 56:1299.
21. Todd M.M., Hindman B.J., Clarke W.R., et al. Perioperative fever and outcome in surgical patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2009, 64:897.
22. Commichau C., Scarmeas N., Mayer S.A. Risk factors for fever in the neurologic intensive care unit. Neurology 2003, 60:837.
23. Rossi S., Zanier E.R., Mauri I., et al. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatr 2001, 71:448.
24. Stocchetti N., Protti A., Lattuada M., et al. Impact of pyrexia on neurochemistry and cerebral oxygenation after acute brain injury. J Neurol Neurosurg Psychiatr 2005, 76:1135.
25. Ginsberg M.D., Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998, 29:529.
26. Rabinstein A.A., Sandhu K. Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors. J Neurol Neurosurg Psychiatr 2007, 78:1278.
27. Kirkness C.J., Burr R.L., Thompson H.J., et al. Temperature rhythm in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2008, 8:380.
28. Yoshimoto Y., Tanaka Y., Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001, 32:1989.
29. Badjatia N., O'Donnell J., Baker J.R., et al. Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter. Neurocrit Care 2004, 1:145.
30. Mayer S.A., Kowalski R.G., Presciutti M., et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med 2004, 32:2508.
31. Diringer M.N. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004, 32:559.
32. Oddo M., Frangos S., Milby A., et al. Induced normothermia attenuates cerebral metabolic distress in patients with aneurysmal subarachnoid hemorrhage and refractory Fever. Stroke 2009, 40:1913.
33. Badjatia N., Strongilis E., Gordon E., et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke 2008, 39:3242.
34. Solomon R.A., Post K.D., McMurtry J.G. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 1984, 15:354.
35. Burnum J.F. Medical vampires. N Engl J Med 1986, 314:1250.
36. Smith M.J., Le Roux P.D., Elliott J.P., et al. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 2004, 101:1.
37. Di Georgia M.A., Deogaonkar A., Ondrejka J., et al. Blood transfusion following subarachnoid hemorrhage worsens outcome [abstract]. Stroke 2005, 36:506.
38. Oddo M., Milby A., Chen I., et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke 2009, 40:1275.
39. Nguyen B.V., Bota D.P., Melot C., et al. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003, 31:406.
40. Pham T.M., Fujino Y., Tokui N., et al. Mortality and risk factors for stroke and its subtypes in a cohort study in Japan. Prev Med 2007, 44:526.
41. Yamada S., Koizumi A., Iso H., et al. History of blood transfusion before 1990 is a risk factor for stroke and cardiovascular diseases: the Japan collaborative cohort study (JACC study). Cerebrovasc Dis 2005, 20:164.
42. Yamada S., Koizumi A., Iso H., et al. Risk factors for fatal subarachnoid hemorrhage: the Japan Collaborative Cohort Study. Stroke 2003, 34:2781.
43. Naidech A.M., Drescher J., Ault M.L., et al. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006, 59:775.
44. Naidech A.M., Jovanovic B., Wartenberg K.E., et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med 2007, 35:2383.
45. Kramer A.H., Gurka M.J., Nathan B., et al. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 2008, 36:2070.
46. Kramer A.H., Zygun D.A., Bleck T.P., et al. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2009, 10:157.
47. Wartenberg K.E., Fernandez A., Frontera J.A., et al. Impact of red blood cell transfusion on outcome after subarachnoid hemorrhage [abstract]. Crit Care Med 2007, 34:A124.
48. McMahon T.J., Moon R.E., Luschinger B.P., et al. Nitric oxide in the human respiratory cycle. Nat Med 2002, 8:711.
49. Smith M.J., Stiefel M.F., Magge S., et al. Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 2005, 33:1104.
50. Moore E.E. Blood substitutes: the future is now. J Am Coll Surg 2003, 196:1.
51. Berezina T.L., Zaets S.B., Morgan C., et al. Influence of storage on red blood cell rheological properties. J Surg Res 2002, 102:6.
52. Forceville X., Plouvier E., Claise C. The deleterious effect of heminic iron in transfused intensive care unit patients. Crit Care Med 2002, 30:1182.
53. Shanwell A., Kristiansson M., Remberger M., et al. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 1997, 37:678.
54. Leal-Noval S.R., Munoz-Gomez M., Murillo-Cabezas F. Optimal hemoglobin concentration in patients with subarachnoid hemorrhage, acute ischemic stroke and traumatic brain injury. Curr Opin Crit Care 2008, 14:156.
55. Corwin H.L., Gettinger A., Pearl R.G., et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002, 288:2827.
56. Siren A.L., Fratelli M., Brines M., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 2001, 98:4044.
57. Bruno A., Biller J., Adams H.P., et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52:280.
58. Kase C.S., Furlan A.J., Wechsler L.R., et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001, 57:1603.
59. Leigh R., Zaidat O.O., Suri M.F., et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004, 35:1903.
60. Alberti O., Becker R., Benes L., et al. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg 2000, 102:78.
61. Lanzino G. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005, 102:974.
62. Lanzino G., Kassell N.F., Germanson T., et al. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1993, 79:885.
63. Frontera J.A., Fernandez A., Claassen J., et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 2006, 37:199.
64. Kruyt N.D., Biessels G.J., de Haan R.J., et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 2009, 40:e424.
65. Lee S.H., Lim J.S., Kim N., et al. Effects of admission glucose level on mortality after subarachnoid hemorrhage: a comparison between short-term and long-term mortality. J Neurol Sci 2008, 275:18.
66. McGirt M.J., Woodworth G.F., Ali M., et al. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007, 107:1080.
67. Schlenk F., Vajkoczy P., Sarrafzadeh A. Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome. Neurocrit Care 2009, 11:56.
68. Pasternak J.J., McGregor D.G., Schroeder D.R., et al. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc 2008, 83:406.
69. Sato M., Nakano M., Asari J., et al. Admission blood glucose levels and early change of neurological grade in poor-grade patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 2006, 148:623.
70. Schlenk F., Frieler K., Nagel A., et al. Cerebral microdialysis for detection of bacterial meningitis in aneurysmal subarachnoid hemorrhage patients: a cohort study. Crit Care 2009, 13:R2.
71. Kitsuta Y., Suzuki N., Sugiyama M., et al. Changes in level of consciousness and association with hyperglycemia as tool for predicting and preventing re-bleeding after spontaneous subarachnoid hemorrhage. Prehosp Disaster Med 2006, 21:190.
72. Dorhout Mees S.M., van Dijk G.W., Algra A., et al. Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003, 61:1132.
73. Latorre J.G., Chou S.H., Nogueira R.G., et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke 2009, 40:1644.
74. Badjatia N., Topcuoglu M.A., Buonanno F.S., et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005, 33:1603.
75. Charpentier C., Audibert G., Guillemin F., et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 1999, 30:1402.
76. Juvela S., Siironen J., Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005, 102:998.
77. Allport L.E., Butcher K.S., Baird T.A., et al. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 2004, 35:1886.
78. Macmillan C.S., Grant I.S., Andrews P.J. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management?. Intensive Care Med 2002, 28:1012.
79. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426.
80. Adams H.P., Putman S.F., Kassell N.F., et al. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 1984, 41:1033.
81. Feigin V.L., Rinkel G.J., Lawes C.M., et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005, 36:2773.
82. Inagawa T. Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo city, Japan. J Neurosurg 2005, 102:60.
83. Kerner A., Schlenk F., Sakowitz O., et al. Impact of hyperglycemia on neurological deficits and extracellular glucose levels in aneurysmal subarachnoid hemorrhage patients. Neurol Res 2007, 29:647.
84. Schlenk F., Nagel A., Graetz D., et al. Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med 2008, 34:1200.
85. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348.
86. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359.
87. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449.
88. Gray C.S., Hildreth A.J., Sandercock P.A., et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007, 6:397.
89. Bell D.A., Strong A.J. Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study. Br J Neurosurg 2005, 19:21.
90. Thiele R.H., Pouratian N., Zuo Z., et al. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology 2009, 110:603.
91. Schlenk F., Graetz D., Nagel A., et al. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care 2008, 12:R9.
92. Oddo M., Schmidt J.M., Carrera E., et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 2008, 36:3233.
93. Hopwood S.E., Parkin M.C., Bezzina E.L., et al. Transient changes in cortical glucose and lactate levels associated with peri-infarct depolarisations, studied with rapid-sampling microdialysis. J Cereb Blood Flow Metab 2005, 25:391.
94. Bilotta F., Spinelli A., Giovannini F., et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007, 19:156.
95. Frontera J.A., Parra A., Shimbo D., et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis 2008, 26:71.
96. Brouwers P.J., Wijdicks E.F., Hasan D., et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke 1989, 20:1162.
97. Sakr Y.L., Lim N., Amaral A.C., et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol 2004, 96:369.
98. Schuiling W.J., Algra A., de Weerd A.W., et al. ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage. Acta Neurochir (Wien) 2006, 148:853.
99. van den Bergh W.M., Algra A., Rinkel G.J. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke 2004, 35:644.
100. Mayer S.A., Fink M.E., Homma S., et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology 1994, 44:815.
101. Banki N.M., Kopelnik A., Dae M.W., et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 2005, 112:3314.
102. Kothavale A., Banki N.M., Kopelnik A., et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 2006, 4:199.
103. Schuiling W.J., Dennesen P.J., Tans J.T., et al. Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatr 2005, 76:1565.
104. Tung P., Kopelnik A., Banki N., et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004, 35:548.
105. Urbaniak K., Merchant A.I., Amin-Hanjani S., et al. Cardiac complications after aneurysmal subarachnoid hemorrhage. Surg Neurol 2007, 67:21.
106. Zaroff J.G., Pawlikowska L., Miss J.C., et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke 2006, 37:1680.
107. van der Bilt I.A., Hasan D., Vandertop W.P., et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 2009, 72:635.
108. Wartenberg K.E., Mayer S.A. Use of induced hypothermia for neuroprotection: indications and application. Future Neurol 2008, 3:325.
109. Naidech A.M., Kreiter K.T., Janjua N., et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005, 112:2851.
110. Gruber A., Reinprecht A., Gorzer H., et al. Pulmonary function and radiographic abnormalities related to neurological outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1998, 88:28.
111. Friedman J.A., Pichelmann M.A., Piepgras D.G., et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery 2003, 52:1025.
112. Kahn J.M., Caldwell E.C., Deem S., et al. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med 2006, 34:196.
113. Kramer A.H., Bleck T.P., Dumont A.S., et al. Implications of early versus late bilateral pulmonary infiltrates in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2009, 10:20.
114. McLaughlin N., Bojanowski M.W., Girard F., et al. Pulmonary edema and cardiac dysfunction following subarachnoid hemorrhage. Can J Neurol Sci 2005, 32:178.
115. Muroi C., Keller M., Pangalu A., et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol 2008, 20:188.
116. Naidech A.M., Bassin S.L., Garg R.K., et al. Cardiac troponin I and acute lung injury after subarachnoid hemorrhage. Neurocrit Care 2009, 11:177.
117. Kim D.H., Haney C.L., Van Ginhoven G. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Neurocrit Care 2005, 3:11.
118. Fisher L.A., Ko N., Miss J., et al. Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH. Neurocrit Care 2006, 5:180.
119. McGirt M.J., Blessing R., Nimjee S.M., et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004, 54:1369.
120. Qureshi A.I., Suri M.F., Sung G.Y., et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2002, 50:749.
121. Sherlock M., O'Sullivan E., Agha A., et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2006, 64:250.
122. Audibert G., Steinmann G., de Talance N., et al. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg 1922, 108:2009.
123. Kubo Y., Ogasawara K., Kakino S., et al. Cerebrospinal fluid adrenomedullin concentration correlates with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Cerebrovasc Dis 2008, 25:164.
124. Katayama Y., Haraoka J., Hirabayashi H., et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:2373.
125. Zeltser D., Rosansky S., van Rensburg H., et al. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007, 27:447.
126. Wright W.L., Asbury W.H., Gilmore J.L., et al. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care 2008, 11:6.
127. Frontera J.A., Fernandez A., Schmidt J.M., et al. Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery 2008, 62:80.
128. Dhar R., Diringer M.N. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care 2008, 8:404.
129. Hirashima Y., Hamada H., Kurimoto M., et al. Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2005, 102:882.